-
1
المؤلفون: A. Jay Gandolfi, Patricia Ostrosky-Wegman, Raúl U. Hernández-Ramírez, Monserrat Sordo, Marcia Hiriart, Gonzalo G. García-Vargas, Susana Bassol, Laura Cruz, Andrea Díaz-Villaseñor, Arturo Cebrián, Walter T. Klimecki, Lizbeth López-Carillo, Mariano E. Cebrián
المصدر: PLoS ONE
PLoS ONE, Vol 8, Iss 1, p e51642 (2013)مصطلحات موضوعية: Male, Mitochondrial Diseases, endocrine system diseases, Epidemiology, medicine.medical_treatment, lcsh:Medicine, Pilot Projects, Type 2 diabetes, 010501 environmental sciences, Toxicology, 01 natural sciences, Endocrinology, Risk Factors, Insulin-Secreting Cells, Insulin Secretion, Insulin, lcsh:Science, 0303 health sciences, Multidisciplinary, Calpain, Environmental exposure, Middle Aged, 3. Good health, Genetic Epidemiology, Medicine, Environmental Pollutants, Female, Research Article, Adult, medicine.medical_specialty, Genotype, Toxic Agents, Single-nucleotide polymorphism, Biology, Polymorphism, Single Nucleotide, Arsenic, 03 medical and health sciences, Insulin resistance, Internal medicine, Diabetes mellitus, medicine, Genetics, Humans, Risk factor, 030304 developmental biology, 0105 earth and related environmental sciences, Aged, Diabetic Endocrinology, Population Biology, lcsh:R, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, Human Genetics, Environmental Exposure, Diabetes Mellitus Type 2, medicine.disease, Biomarker Epidemiology, Diabetes Mellitus and Deafness, Diabetes Mellitus, Type 2, Genetic Polymorphism, lcsh:Q, Insulin Resistance, Population Genetics
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2a87a742792b23d7e73b2d476b61548Test
https://pubmed.ncbi.nlm.nih.gov/23349674Test -
2
المؤلفون: Nathan J. Cherrington, April D. Lake, Rhiannon N. Hardwick, A. Jay Gandolfi, Walter T. Klimecki, George L. Scheffer, Michael J. Kopplin, Mark J. Canet
المساهمون: CCA - Immuno-pathogenesis, Pathology
المصدر: Drug Metabolism and Disposition, 40(9), 1817-1824. American Society for Pharmacology and Experimental Therapeutics
Canet, M J, Hardwick, R N, Lake, A D, Kopplin, M J, Scheffer, G L, Klimecki, W T, Gandolfi, A J & Cherrington, N J 2012, ' Altered arsenic disposition in experimental nonalcoholic Fatty liver disease ', Drug Metabolism and Disposition, vol. 40, no. 9, pp. 1817-1824 . https://doi.org/10.1124/dmd.112.046177Testمصطلحات موضوعية: Male, medicine.medical_specialty, Pharmaceutical Science, chemistry.chemical_element, Biology, Diet, High-Fat, Kidney, digestive system, Arsenicals, chemistry.chemical_compound, Mice, Methionine, Arsenic Trioxide, Non-alcoholic Fatty Liver Disease, Internal medicine, Nonalcoholic fatty liver disease, medicine, Animals, Arsenic trioxide, Arsenic, Biotransformation, Pharmacology, Fatty liver, Kidney metabolism, nutritional and metabolic diseases, Oxides, Methyltransferases, Articles, medicine.disease, digestive system diseases, Choline Deficiency, Fatty Liver, Mice, Inbred C57BL, Disease Models, Animal, Endocrinology, chemistry, Liver, Toxicity, Arsenates, Environmental Pollutants, Sodium arsenate, Multidrug Resistance-Associated Proteins, Toxicant
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c90f161a92098526632c40e2398754Test
https://pubmed.ncbi.nlm.nih.gov/22699396Test